Koshinski Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.12M | Buy |
5,099
+316
| +7% | +$323K | 0.33% | 68 |
|
|
2026
Q1 | $4.4M | Sell |
4,783
-59
| -1% | -$59.8K | 0.27% | 83 |
|
|
2025
Q4 | $5.2M | Buy |
4,842
+57
| +1% | +$54.5K | 0.34% | 61 |
|
|
2025
Q3 | $3.65M | Buy |
4,785
+112
| +2% | +$83.3K | 0.25% | 89 |
|
|
2025
Q2 | $3.64M | Buy |
4,673
+391
| +9% | +$304K | 0.28% | 77 |
|
|
2025
Q1 | $3.54M | Buy |
4,282
+23
| +0.5% | +$19.1K | 0.3% | 74 |
|
|
2024
Q4 | $3.29B | Sell |
4,259
-17
| -0.4% | -$14.1K | 0.28% | 80 |
|
|
2024
Q3 | $3.79M | Sell |
4,276
-354
| -8% | -$318K | 0.33% | 66 |
|
|
2024
Q2 | $4.32M | Buy |
4,630
+117
| +3% | +$93.6K | 0.4% | 52 |
|
|
2024
Q1 | $3.51M | Buy |
4,513
+965
| +27% | +$687K | 0.36% | 62 |
|
|
2023
Q4 | $2.07M | Sell |
3,548
-747
| -17% | -$436K | 0.31% | 88 |
|
|
2023
Q3 | $2.31M | Buy |
4,295
+151
| +4% | +$77.8K | 0.27% | 87 |
|
|
2023
Q2 | $1.94M | Sell |
4,144
-796
| -16% | -$334K | 0.21% | 109 |
|
|
2023
Q1 | $1.7M | Sell |
4,940
-107
| -2% | -$36.1K | 0.17% | 129 |
|
|
2022
Q4 | $1.85M | Sell |
5,047
-17
| -0.3% | -$6.03K | 0.18% | 130 |
|
|
2022
Q3 | $1.64M | Sell |
5,064
-264
| -5% | -$83.6K | 0.2% | 126 |
|
|
2022
Q2 | $1.73M | Buy |
5,328
+479
| +10% | +$144K | 0.17% | 139 |
|
|
2022
Q1 | $1.39M | Buy |
4,849
+38
| +0.8% | +$9.78K | 0.11% | 187 |
|
|
2021
Q4 | $1.33M | Buy |
4,811
+54
| +1% | +$13.7K | 0.11% | 200 |
|
|
2021
Q3 | $1.1M | Buy |
4,757
+936
| +24% | +$231K | 0.1% | 232 |
|
|
2021
Q2 | $877K | Sell |
3,821
-1,118
| -23% | -$225K | 0.11% | 210 |
|
|
2021
Q1 | $923K | Buy |
4,939
+1,862
| +61% | +$364K | 0.1% | 242 |
|
|
2020
Q4 | $520K | Buy |
3,077
+157
| +5% | +$23.4K | 0.07% | 309 |
|
|
2020
Q3 | $451 | Sell |
2,920
-68
| -2% | -$10.5K | 0.06% | 313 |
|
|
2020
Q2 | $491K | Sell |
2,988
-73
| -2% | -$11.2K | 0.08% | 280 |
|
|
2020
Q1 | $425K | Buy |
3,061
+22
| +0.7% | +$3.02K | 0.09% | 267 |
|
|
2019
Q4 | $399K | Buy |
3,039
+1,222
| +67% | +$142K | 0.07% | 353 |
|
|
2019
Q3 | $203K | Hold |
1,817
| – | – | 0.14% | 146 |
|
|
2019
Q2 | $201K | Sell |
1,817
-330
| -15% | -$38.9K | 0.08% | 260 |
|
|
2019
Q1 | $279 | Sell |
2,147
-3,349
| -61% | -$407K | 0.07% | 301 |
|
|
2018
Q4 | $636K | Sell |
5,496
-4,334
| -44% | -$484K | 0.16% | 184 |
|
|
2018
Q3 | $1.05M | Buy |
9,830
+4,417
| +82% | +$442K | 0.15% | 196 |
|
|
2018
Q2 | $462K | Sell |
5,413
-319
| -6% | -$26.2K | 0.14% | 221 |
|
|
2018
Q1 | $443K | Sell |
5,732
-1,912
| -25% | -$154K | 0.14% | 227 |
|
|
2017
Q4 | $646K | Buy |
7,644
+1,297
| +20% | +$110K | 0.16% | 215 |
|
|
2017
Q3 | $543K | Buy |
6,347
+132
| +2% | +$10.8K | 0.18% | 188 |
|
|
2017
Q2 | $511K | Buy |
6,215
+283
| +5% | +$23.1K | 0.19% | 186 |
|
|
2017
Q1 | $499K | Buy |
5,932
+2,492
| +72% | +$200K | 0.2% | 155 |
|
|
2016
Q4 | $253K | Sell |
3,440
-410
| -11% | -$30.5K | 0.13% | 236 |
|
|
2016
Q3 | $309K | Buy |
3,850
+78
| +2% | +$6.24K | 0.15% | 209 |
|
|
2016
Q2 | $297K | Buy |
3,772
+1,400
| +59% | +$105K | 0.16% | 196 |
|
|
2016
Q1 | $248K | Buy |
+2,372
| New | +$179K | 0.16% | 186 |
|
Other funds holding LLY
SC
ONB
GIM
Koshinski Asset Management's LLY Position: Q2 2026 in Review
Koshinski Asset Management increased its Eli Lilly (LLY) stake by 6.6% in Q2 2026, buying an estimated $323K and bringing the position to 5,099 shares worth $6.12M. The position accounts for 0.33% of the portfolio, ranked #68.
Koshinski Asset Management first reported a position in LLY in Q1 2016 and has held it in 42 quarters since. The position peaked at $3.29B in Q4 2024. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Koshinski Asset Management held 5,099 shares of Eli Lilly worth $6.12M as of Q2 2026.
- Koshinski Asset Management bought 316 Eli Lilly shares in Q2 2026, an estimated $323K.
- Eli Lilly made up 0.33% of Koshinski Asset Management's portfolio in Q2 2026, its #68 holding.
- Koshinski Asset Management first reported a position in Eli Lilly in Q1 2016 and has held it in 42 quarters since.
- Koshinski Asset Management's Eli Lilly position peaked at $3.29B in Q4 2024.
- 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.